Nan Kuang Pharmaceutical Co., Ltd.: 2026 Q1 EPS 0.32 NTD
NQ Score
0/100
N1 Content Completeness
4
AI Summary (NQ-processed)
Nan Kuang Pharmaceutical Co., Ltd. announced its Q1 2026 financial results, reporting an EPS of 0.32 NTD, revenue of 530 million NTD, and net income of 32 million NTD.